Advanced MedTech makes strategic investments in category disruptive technologies in the healthcare sector.
To date, Advanced MedTech has made 10 M&A strategic transactions.
Leveraging a strong track record in taking medical innovations from development through to regulatory
approvals and commercialisation, we invest in high-growth, well-run healthcare technology companies.
Recent M&A Transactions:
Unlocking the Future of Dialysis
Advent Access is a medical technology startup in end stage renal disease management. Founded based on Stanford Biodesign principles and as a spin-off from A*STAR, Advent Access' first product is the av-Guardian™, a device that improves vascular access reliability, reduces cannulation pain and in the long run, preserves the health of an arteriovenous fistula. The av-Guardian™ forms a key component of Advent Access' dialysis-machine agnostic platform to empower patients to perform hemodialysis independently, safely and more affordably.
Changing Dialysis Forever
AWAK Technologies is a medical technology company, founded in 2007 that is dedicated to transforming the lives of patients suffering from kidney disease. The company has developed a patented sorbent technology which revolutionizes dialysis by reducing the amount of dialysate required. This technology enables the development of light-weight, compact, automated wearable and portable medical devices.
Breathing New Life into Traditional Therapies™
Founded in 2017, ABM Respiratory Care is a medical device startup focused on developing novel integrated airway clearance and ventilation solutions for people suffering from pulmonary complications and diseases. In 2020, the company launched the world's first televentilator, the Alpha Ventilator, designed to allow remote management and monitoring of ventilators to reduce the number of bedside visits. The company also launched the biWaze Airway Clearance System, designed to provide a tailored and hygienic therapy.